Overview
A leading department store retailer with a predominantly non-desk, hourly workforce needed a chronic care partner that could drive meaningful engagement and outcomes, and help manage GLP-1 spend, without adding complexity. Life for the company's associates is anything but linear. Shifts change, priorities collide, and for a large portion of the population, their cardiometabolic health took a back seat. The company sought a solution that could adapt to these realities.
By partnering with Omada in 2023 for diabetes and hypertension management, and implementing Evernorth's EncircleRx in 2025, the retailer consolidated cardiometabolic care into one integrated solution. They expanded coverage to include prevention, weight health, and GLP-1 support and the results have been substantial: over 9,000 pounds lost, improved diabetes and hypertension control, and a streamlined benefits experience that a lean HR team can manage effectively.
The Challenge: Complex Population, Fragmented Care
The retailer's workforce includes roughly 900 corporate associates and 17,000 non-desk associates across stores and distribution centers. Many do not have company emails or regular access to desktop devices, and traditional one-size-fits-all benefit programs weren't delivering results.
The company faced several interrelated challenges:
- Rising GLP-1 costs and utilization: As GLP-1 therapies grew in popularity, the company needed to manage costs and prove ROI. They also needed to ensure appropriate clinical use without adding administrative burden.
- High prevalence of cardiometabolic disease: Diabetes, hypertension, and related conditions were widespread. Associates needed ongoing access to medications, supplies, coaching, and clinical oversight.
- Strong demand for weight management: Internal surveys showed weight health programs were "very popular" among associates. However, existing solutions weren't engaging or effective.
- Fragmented vendor ecosystem: Managing multiple point solutions for diabetes, hypertension, weight, and medications created administrative complexity and inconsistent member experiences.
- Limited internal resources: With a benefits team of one, the company needed a partner that could simplify administration and drive engagement, not create more work.
The retailer sought virtual care that could support many health journeys through one multi-condition partner. They wanted to reduce complexity instead of layering on more vendors, and needed protection from budget shocks as therapies like GLP-1s evolved.
The Solution: Omada + EncircleRx for Integrated Cardiometabolic Care
The retailer transitioned to Omada in 2023 to consolidate chronic condition management under one adaptive, multi-condition platform. Shortly after, the company adopted Evernorth's EncircleRx to create clinical and financial guardrails around GLP-1 use. This allowed for seamless integration between medication management and behavioral support.
One Platform for Multiple Conditions
To streamline its cardiometabolic care benefit, the retailer partnered with Omada to address the most common chronic conditions among its workforce: diabetes, hypertension, and obesity.
More than a quarter of U.S. adults manage multiple chronic conditions simultaneously, and the retailer's workforce reflects this reality. Since these conditions often overlap and compound one another—for example, obesity can contribute to both diabetes and hypertension—holistic lifestyle support was essential. A one-size-fits-all approach wouldn't work for this complex population, so tailored interventions became key to improving health outcomes and reducing medical spend.
The retailer implemented Omada’s full offering of cardiometabolic care programs, including Prevention through EncircleRx, Diabetes, and Hypertension in partnership with Evernorth. Associates choose their personal care paths to get the tailored support they need to improve their health.
How EncircleRx Closes the Gap Between Prescription and Results
When a member is prescribed a GLP-1 medication by their primary care provider, the member is automatically enrolled into the EncircleRx program. This means that they receive the behavioral support, nutrition guidance, side effect management, and coaching needed to achieve results. The integration eliminates the disconnect that often exists between pharmacy benefit management and chronic care programs. It creates a cohesive experience that supports both medication adherence and sustainable lifestyle change.
For this retailer, the combined solution means:
- Clinical appropriateness: EncircleRx confirms GLP-1 prescriptions meet evidence-based criteria. This reduces unnecessary spend while supporting members who truly benefit.
- Behavioral integration: Members aren't just handed a prescription, they're enrolled in Omada’s adaptive coaching, nutrition support, exercise guidance, and community resources.
- Reduced administrative burden: The retailer doesn't need to manage GLP-1 oversight separately or chase down engagement. Evernorth and Omada handle enrollment, coordination and reporting.
Because the client has added Diabetes and Hypertension support in addition to the EncircleRx program, each associate's level of support can flex up or down as needed. This might mean lifestyle coaching for lower-risk members and added oversight from Certified Diabetes Care and Education Specialists for Diabetes, Hypertension and GLP-1 Care Track members.
Tailored Outreach: Meeting Associates Where They Are
To reach a population where the majority of associates are on their feet without corporate email, the retailer and Omada co-designed a custom engagement strategy.
- Targeted email outreach for those with company or personal email access to drive timely enrollment.
- Frontline communication to all in-store associates via retail operations software.
- Persistent banners and digital benefit ads on the company intranet and office TVs to keep Omada visible and accessible.
- Integration into the benefits site, positioning Omada as a core part of the company's health ecosystem rather than an isolated program.
- Posters in retail stores and distribution centers to reach associates on the sales floor and in the warehouse.
- Periodic benefits webinars that allow associates to hear about health and wellness programs like Omada, ask questions, and see how they fit into the broader benefits strategy.
- A $100 HSA incentive for participation, reinforcing that the company is willing to invest in associates' health journeys.
- Social media storytelling that highlights Omada and other health benefits as part of recruitment and retention messaging. This underscores that the company cares about associates' well-being.
Results: Solving Population Health Challenges at Scale
The retailer’s partnership with Omada and Evernorth’s EncircleRx is delivering both quantifiable outcomes and qualitative value that directly address the retailer's original challenges.
Durable Outcomes Across Conditions
Across Omada's programs, associates have collectively lost more than 9,000 pounds. This is a tangible indicator that the support is not just engaging people, but helping them make sustained changes. Combined with improved management of diabetes and hypertension, this weight loss can translate into meaningful cardiometabolic risk reduction across the population.
High Engagement Across a Complex, Distributed Workforce
Through multi-channel outreach and Omada's adaptive design, the company reaches both corporate and non-desk associates. This includes many who might have been overlooked by more rigid or email-dependent programs. The combination of digital tools, human coaching, and in-person touchpoints provides associates with support they need to participate in the program and benefit regardless of their work environment or tech access.
Reduced Complexity and Vendor Consolidation
Instead of juggling multiple siloed point solutions for diabetes, hypertension, weight, and GLP-1 management, the company now relies on one integrated partner. Omada and EncircleRx together address prevention, weight, cardiometabolic risk, sleep, stress, medication support, and GLP-1 oversight. This simplifies vendor management, reduces administrative burden, and creates a more coherent experience for members.
Protection from Rising GLP-1 Costs
With EncircleRx, the company has set appropriate clinical and financial guardrails around GLP-1 use. The integration connects expensive therapies to behavior change, coaching, and integrated chronic care. This protects the organization from unmanaged budget shocks while ensuring members who may benefit from these medications receive comprehensive support for long-term success.
Conclusion
Grounded in over a decade of experience and more than two million individual care journeys, Omada enables organizations to align their chronic care strategy with how health actually works: unevenly, imperfectly, and uniquely for each person. For this national retailer, the partnership between Omada and Evernorth helped solve core population health challenges. These included unaddressed cardiometabolic conditions, fragmented care, rising costs, engagement barriers, and administrative complexity. The solution delivered adaptive, integrated support that works for real life. For associates, this means a program that adapts to their lives, not the other way around. For the benefits team, it means meaningful outcomes without added burden. And for the organization, it means a sustainable, scalable solution built for today's workforce and tomorrow's therapies.
